Bristol-Myers to buy Celgene in a $74 billion deal; Celgene shares surge By: Top News and Analysis (pro) January 03, 2019 at 07:03 AM EST Bristol-Myers on Thursday announced plans to buy Celgene in a deal the company valued at $74 billion. Read More >>